Clinical Trial Update: A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of a three-drug antiretroviral regimen (abacavir + indinavir sulfate + efavirenz) in HIV infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Indinavir sulfate (indinavir)
• abacavir (abacavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED